abstract CONTEXT: Although effective health and nutrition interventions for reducing child mortality and morbidity exist, direct evidence of effects on cognitive, motor, and psychosocial development is lacking.
Despite recent improvement, in children <5 years old, high rates of mortality and morbidity, poverty, and chronic undernutrition are pervasive in many low-and middleincome countries (LMIC). For children who survive infancy, many remain at a high risk for stunted growth and impaired development. In 2014, ~23.8% of children (159 million) <5 years old were stunted1 and at a high risk of impaired child development. 2 The Lancet's 2016 Early Child Development Series 3 estimated that based on stunting and extreme poverty, 43% of children (249.4 million) <5 years old in LMIC were at risk for suboptimal development, 4 which effectively forfeits a quarter of the annual adult income because of lost cognitive potential and reduced productivity. 5 Recent predictive modeling that used the Human Development Index, nutrition status, and Early Child Development Index data (from the Multiple Indicator Cluster Survey and Demographic Health Survey) suggests that 36.8% of children (80.8 million) ages 3 to 4 years in LMIC do not reach fundamental cognitive or socioemotional development milestones. 6 Moving forward, achieving the Sustainable Development Goals of zero hunger (Goal 2), good health and well-being at all ages (Goal 3), and quality and equitable education (Goal 4) will require maximizing every opportunity to institute appropriate interventions at scale.
To assist in selecting and prioritizing key interventions, we developed a conceptual framework of risk factors and opportunities for interventions across the life course (Fig 1) . 7 -9 For this overview, we were focused on the biological risk factors for suboptimal development, which broadly include undernutrition, infectious disease, and toxin exposure, 10 many of which affect both child survival and development. 7 There is also evidence for an intergenerational impact of early stunting on child development 11 and a potential second window of opportunity for supporting development in the adolescent period. 12 A variety of interventions that support maternal, newborn, and child health and nutrition (MNCH&N) have been identified as both effective and feasible for scale-up. The rationale for focusing on interventions that target the "First 1000 Days" of life (from conception to 2 years of age) is that the mitigation of risk factors during this critical period has substantial benefits over the life course. 13 There is evidence to suggest, however, that this period may be somewhat arbitrary because highly effective interventions also exist for the preconception period, late childhood, and adolescence that could benefit developmental outcomes. Nevertheless, supporting development in utero and early life is important and is when much of the fetal morbidity, stillbirths, and <5 years of age child mortality is concentrated. 3 With an increasing number of children surviving infancy, the importance of enhancing the survival agenda 7 to reduce morbidity and support child development is evident. Table 1 summarizes the theoretical rationale for the beneficial neurodevelopmental impacts of a variety of interventions at various time points. Particularly impactful targets ameliorate maternal malnutrition and infection during preconception and pregnancy, which contribute to intrauterine growth restriction (IUGR), children being born small for gestational age (SGA), or preterm births, and neonatal infections. In addition to the developmental risks associated with maternal iodine deficiency 10 and folic acid deficiency, 14 recent evidence demonstrating the link between Zika virus infection during pregnancy and subsequent microcephaly in some infants 15 highlights the potential infectious risks to neurodevelopment in utero. 16 Postnatally, reducing environmental enteropathy is key because it may mediate the relationship between poor personal and food hygiene and environmental factors that contribute to developmental deficits through chronic intestinal mucosal, systemic inflammation, 17 and nutrient malabsorption. 18 Both acute malnutrition and stunted growth in childhood are associated with poorer cognitive and motor development. 19 Despite these obvious links, most studies or programs of MNCH&N interventions typically only measure proximal measures, such as anthropometry, birth outcomes, or clinically apparent health outcomes. The associations between these intermediate outcomes and brain development are not only biologically plausible but have been demonstrated, 20 and they include IUGR, 21 preterm birth, 22 and neonatal insults 23 among others.
By building on recent overviews of evidence-based MNCH&N interventions, 36 -40 we synthesized the outcome data on indirect risks and direct measures of early child development. We also mapped the outcome data to identify gaps in the evidence where additional research is needed.
METhODs

Identifying the Universe of Interventions to Assess
We identified (from recently published overviews) a universe of evidence-based interventions that have been identified in the literature as supporting MNCH&N and could plausibly affect early child development. The source overviews included relevant Lancet series 36 -38 and summaries of essential intervention packages. 39, 40 We restricted ourselves to interventions that target the biological risk factors for impaired child development and thus did not examine interventions related to education, poverty alleviation, the built environment, or other sectors that affect the social determinants of health.
Review selection and Eligibility screening
From the listing of interventions in each overview, citations for the corresponding systematic reviews and meta-analyses were extracted from the reference lists. We conducted relevant keyword searches in Medline, PubMed, and the Cochrane Database of Systematic Reviews for more recent reviews of pertinent interventions that were published in the past 2 years that may not have been captured in the overviews. Hand searching of relevant literature was also done to identify existing or forthcoming systematic reviews or meta-analyses for which data were available. Nonsystematic reviews, drug comparisons, reviews with no childrelated outcome data, and those superseded by newer publications were excluded. Also excluded were reviews that focused on life-saving interventions to prevent maternal or perinatal mortality. If a cited Cochrane review had been updated, the most recent published version (up to April 1, 2016) was selected for data extraction. Promote optimal breastfeeding 9 and complementary feeding practices to protect against malnutrition, infection, enteropathy, 18 and linear growth stunting 10 and optimize gut microbiome development. 32 Ensure adequate psychosocial stimulation 10 is provided during the period of rapid brain development. Prevent and treat acute malnutrition and micronutrient deficiencies to prevent cognitive deficits. 10 Infectious disease prevention and management in infancy and childhood
Provide routine childhood vaccinations and malaria prophylaxis, 10 which can prevent and mitigate direct neurologic damage from infectious agents. Support access to safe water, improve sanitation infrastructure, and promote hygienic practices to protect against environmental enteropathy and its sequelae. 18 Reducing exposure to toxins and environmental contaminants
Minimize indoor air pollution to prevent placental pathology 33 and neurodevelopmental deficits. 34 Reduce lead and arsenic exposure 10 at home and in the workplace to protect against cognitive deficits. Support smoking cessation during pregnancy to prevent neurobehavioral deficits in children, 35 and address maternal drug and alcohol exposure.
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Data Extraction and Quality Assessment
Two reviewers used a standardized form to independently extract each review's characteristics, meta-analyzed the outcome data (including pooled effect sizes, confidence intervals, study counts, and heterogeneity), and performed A Measurement Tool to Assess Systematic Reviews (AMSTAR) quality assessments. 41 Any disagreements in the subjective quality ratings were resolved by consensus or a third reviewer. Additionally, we reviewed the focus, reported outcomes and characteristics of each study included within each review, retrieved the full text when relevant, and extracted any summary outcome data related to direct measures of child development.
Targeted Outcome Mapping
Interventions that included ≥1 statistically significant effect on an anthropometric, nutritional, severe morbidity or disability outcome or a direct measure of development (eg, Bayley Scales of Infant Development score or Ages and Stages Questionnaire score) were included in our final list of interventions with impact estimates. This encompassed direct effects on child development as well as effects on intermediate outcomes that are linked to development through a pathway related to malnutrition and infectious disease morbidity. Nonsignificant effect estimates for outcomes of interest for each included intervention are also displayed.
REsULTs
In total, 120 systematic reviews were selected for full data extraction, 60 of which were included in the outcome mapping exercise (see Fig  2) . All but 1 of these received an AMSTAR rating of medium or high quality. Review characteristics, pooled effect estimates, and quality ratings are reported in Supplemental Table 7 . Select interventions that had statistically significant effects on the outcomes of interest are highlighted below. The corresponding source overview for each highlighted intervention is summarized in Supplemental Figure 6 .
Figure 3 displays a mapping of the outcomes reported in systematic reviews of the effectiveness of 35 selected interventions or intervention categories with promising effects on developmentally relevant outcomes. These are also depicted within a conceptual framework in Fig 4. Most commonly reported were birth outcomes for interventions delivered during preconception and pregnancy, growth outcomes and disease morbidity for interventions delivered during infancy and childhood, and mortality throughout these critical windows. Out of 60 reviews of interventions in which ≥1 statistically significant effect on an outcome of interest had been reported, only 16 reviews covering 13 discrete interventions reported summary estimates for outcomes that were direct measures of child development. Pooled data on direct measures of child development reported in metaanalyses often consisted of a small number of studies with relatively few participants when compared with other outcome types. Effect estimates for outcomes that directly measure child development and study characteristics of individual studies found within the reviews' meta-analyses are reported in Supplemental Table 8 . Data for those individual studies with the direct measurements of child development included in reviews but not presented within their meta-analyses are found in Supplemental Table 9 .
Preconception and Antenatal Care
Early preventive interventions that seek to minimize rates of SGA, prematurity, and newborn complications include supporting access to family planning and antenatal care services and an optimal environment for fetal growth (Table  2) . Family planning for promoting 4 
FIGURE 2
Overview flow diagram.
by 145603 on August 1, 2017 Downloaded from longer birth intervals can improve birth outcomes, 42 and preconception diabetes care can reduce perinatal mortality and congenital malformations. 43 Antiplatelet agents can prevent preeclampsia in at-risk women, improve infant growth and birth outcomes, and prevent motor deficits in infancy. 27 Infection and inflammation during pregnancy negatively influence fetal growth and development. Malaria prophylaxis; 44 -46 antibiotic treatment of asymptomatic bacteriuria, 47 a confirmed infection, 48 or preterm membrane rupture 49 ; and smoking cessation interventions 50 can all
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FIGURE 3
Mapping of the outcomes reported in reviews of the impact of interventions across the continuum of care. Bold text shows pooled outcome(s) reported with significant beneficial effect(s). Regular text shows pooled outcome(s) reported with nonsignificant effect(s). Italic text shows pooled outcome(s) reported with significant detrimental effect(s). a Pooled outcomes reported in 2 or more separate meta-analyses with both significant beneficial and nonsignificant and/or detrimental effects (eg, different subgroups). b Effects from observational data, rather than a family planning intervention.
by 145603 on August 1, 2017 Downloaded from improve pregnancy and birth outcomes. Magnesium sulfate given to mothers who are at risk for preterm birth reduce infants' risk of cerebral palsy and gross motor dysfunction. 28 In appropriate populations, 51 antenatal corticosteroids for women who are at risk for preterm birth prevent intracranial hemorrhage and developmental delay in childhood 52 as well as neonatal mortality in both high-and low-income settings. 53 
Nutrition During Preconception and Pregnancy to Optimize Fetal Growth and Development
Adequate macronutrient intake is essential for optimal fetal growth and development, and balanced protein-energy supplementation during pregnancy improves fetal growth and birth outcomes, with greater effects observed in malnourished women. 54 Provision of nutrient supplements to foodinsecure or wasted expectant mothers supports optimal growth and development both in the womb and after birth (Table  3 ). The significant effects of the aforementioned interventions on key birth outcomes are summarized in Fig 5. Adequate micronutrient intake is essential for satisfying the physiologic requirements of a developing fetus. Ideally, interventions to address maternal undernutrition and micronutrient deficiencies should start in the preconception period. 55 Folic acid supplementation 56 and fortification 57 during preconception effectively prevents neural tube defects. During pregnancy, folic acid also improves birth weight, 43 and iodine supplementation in deficient populations prevents cretinism and infant mortality and improves cognitive development. 58 Observational studies reveal that the use of iodized salt in at-risk populations is a cost-effective way to improve iodine status and confers substantial benefits to cognition. 58 Iron supplementation during pregnancy 59 improves birth outcomes and infant iron status in areas with high malarial burden, with potential developmental benefits seen in areas with a high burden of iron deficiency (See Supplemental Table 9 ). A Cochrane review reveals that multiple micronutrient (MMN) supplementation during pregnancy 60 can reduce the prevalence of SGA, low birth weight, and preterm births, with potential cognitive and motor development benefits (see Supplemental Table 9 ) and gains in head circumference 61 in the offspring of undernourished mothers. Notwithstanding these potential benefits, a recent review 61 of MMN supplementation in pregnancy did not find any developmental benefits in the limited set of studies that had measured such outcomes.
Care During Labor, Birth, and the Neonatal Period to Prevent Complications and Morbidity
The provision of appropriate and skilled care during labor, birth, and the immediate newborn period should be afforded to all infants, with additional protective interventions for at-risk neonates (Table 4) . Of newborns, ∼3% to 6% require basic resuscitation at birth, and providing training in neonatal resuscitation impacts neonatal mortality. 62, 63 Skilled birth attendance in community settings reduces perinatal and early neonatal mortality and risks of morbidity associated with intrapartum complications. 64 Social support for women during childbirth has been shown to improve Apgar scores in neonates, which underscores the importance of addressing maternal anxiety and stress. 63 Appropriate aftercare and strategies to protect the brains of newborns after birth asphyxia can further mitigate neurodevelopmental deficits and disabilities. Therapeutic hypothermia for newborns with hypoxic ischemic encephalopathy reduces the risk of developmental delay and cerebral palsy, although evidence is currently lacking from LMIC. 65 Delayed cord clamping in preterm neonates reduce the risks for intraventricular hemorrhage 23, 66 and anemia, 66 but the reported effects on neurodevelopment are mixed. 67 In addition to its survival benefits, Kangaroo Mother Care (KMC) in preterm infants has been shown to improve mother-infant attachment,
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FIGURE 4
Conceptual framework of key interventions in early life that support optimal child growth and development.
rates of exclusive breastfeeding, and growth rates 68 and prevent pneumonia, sepsis, jaundice, 69 and hypothermia. 70 Skin-to-skin contact, which is a core component of KMC, can improve measures of infant cardiorespiratory stability. 71 Topical emollient therapy for preterm infants, which is a neonatal skincare strategy for hypothermia and infection prevention, can improve infant growth 72 and prevent hospitalacquired infections and neonatal mortality. 73 Cleminson and McGuire 72 conducted a small study and showed improved psychomotor development in low-risk preterm neonates (see Supplemental Table 9 ). Massage therapy in preterm infants has been found to promote weight gain when coconut or sunflower oil is used. 74 
Nutrition During Infancy and Childhood for Optimal Growth and Development
A variety of effective nutritional interventions exist that are delivered during infancy and childhood, when rapid growth and development occur (Table 5) . Breast milk regulates infant immunity, metabolic processes, and brain development, which are mediated through the establishment of the intestinal microbiome. 75 Optimal breastfeeding is linked to significant reductions in infectious disease mortality, diarrhea, and lower respiratory infections. 76 -78 Breastfeeding can impact cognitive development during infancy, and whereas there is debate about the magnitude of effect, 79, 80 meta-analysis of observational data 81 and a single randomized controlled trial 82 suggest improved intelligence. Various effective breastfeeding education or support interventions exist that increase the coverage of early and exclusive breastfeeding 83 with a consistently larger effect size in LMIC settings. 84 by 145603 on August 1, 2017 Downloaded from series 85 outlined a variety of sectors in which breastfeeding promotion is effective at improving early and exclusive breastfeeding rates. 86 Given the link between childhood anemia and cognition, 87 there is interest in addressing childhood deficiency in iron and other micronutrients. A Cochrane review 88 of intermittent iron supplementation in children 0 to 12 years old found improvements in motor development but a decrease in IQ. In another review, Sachdev, Gera, and Nestel 89 examined iron supplementation in children 0 to 15 years old and found improvements in mental development scores. MMN supplementation can improve motor development in infants 6 to 12 months old and academic performance in school-aged children. 90 Reductions in iron deficiency anemia have also been observed 91 in addition to better motor milestone attainment (see Supplemental Table  9 ). Vitamin A supplementation in children effectively reduces vitamin A deficiency and associated morbidities, 92 including reductions in all-cause and diarrhea-associated mortality. 92 Complementary feeding education for parents in food-secure populations improves infant growth and also decreases stunting in food-insecure populations. 93 Food provision in food-insecure populations can 8 CI, confidence interval; HIC, high-income country; MD, mean difference; RR, risk ratio; SMD, standard mean difference; SR, systematic review.
FIGURE 5
Range of effects of interventions during pregnancy on birth outcomes. BEP, balanced protein-energy; CI, confidence interval; IFA, iron-folic acid; IPTp, intermittent preventive therapy for malaria during pregnancy; ITN, insecticide treated nets; LGTI, lower genital tract infection.
by 145603 on August 1, 2017 Downloaded from prevent stunting, being underweight, and respiratory infections. 93 Supplementary feeding for healthy but socioeconomically disadvantaged children <5 years old in LMIC improves hemoglobin, growth, and psychomotor development, 94 but reported effects on cognition were mixed. 94 Chronic protein and caloric deficits during acute malnutrition lead to stunting and wasting and contribute to suboptimal neurodevelopment, and treatment with specially formulated therapeutic foods can facilitate recovery. 95, 96 
Infection Prevention and Control During Childhood
Strategies for preventing and mitigating childhood infection are essential to optimizing child health and development (Table 6 ). Routine childhood vaccines are effective in reducing both morbidity and mortality, particularly from measles, 97 diarrhea, 98 and pneumonia. 99 Interventions that improve the uptake of clean water, sanitation infrastructure, and optimal hygiene practices can prevent diarrhea and other water-borne diseases and reduce environmental enteropathy, 36 although there are few direct measures of developmental benefits. Promotion of optimal hand-washing and water quality-improvement strategies can improve weight for age and height for age among girls 100 and reduce diarrheal morbidity, 101 with some evidence of gains in development quotients at 5 to 7 years (See Supplemental Table 9 ).
Zinc as a diarrhea treatment can improve growth 102 and reduce persistent diarrhea. 103 Zinc supplementation among healthy children can mitigate the severity of diarrhea, reduce zinc deficiency, and increase height and weight. 104 Gogia and Sachdev 105 conducted a review of the effect of zinc supplementation on mental and motor development in children and concluded that there was insufficient evidence of developmental benefits in young children.
Intermittent preventive treatment among children who live in malariaendemic areas can prevent severe malaria and anemia 106 and improve hemoglobin 107 in anemic children. A Cochrane review of deworming infected children showed improved growth, but presumptive treatment within population settings (such as mass deworming programs) has not been shown to have significant growth or developmental benefits, 108 which is a finding that is echoed by a recent network meta-analysis on mass deworming. 109 
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DIsCUssION
This overview has several limitations inherent to the search strategy that was used, and as such, it cannot comprehensively represent the full extent of the potential impact of MNCH&N interventions on child development. Studies that contributed to the pooled estimates reported here were selected on the basis of the included systematic reviews, which may not have focused on developmental impacts.
We mitigated this by specifically scanning for and including developmental impacts that were not reported in the main reviews. We do recognize that incomplete reporting of study characteristics at the review level may have excluded potentially relevant study-level data.
Despite the large volume of the literature reviewed, and although effects on anthropometry, morbidity, and survival were consistently reported, our analysis shows a remarkable paucity of the direct measures of child development outcomes reported in both reviews and studies of interventions, which would plausibly have developmental impacts. In many instances, this could be related to study designs, primary objectives, and the duration of follow-up. For example, studies of asphyxia prevention and management typically only assessed outcomes in the short-term, such as neonatal mortality, hypoxia, and encephalopathy. In other cases, the by 145603 on August 1, 2017 Downloaded from dearth of developmental measures is potentially related to the difficulty in assessing such outcomes in addition to mortality and morbidity. The available evidence suggests that benefits to development can be derived from maternal and child nutrient supplementation and protective interventions for at-risk infants both before and after birth. In fairness, most interventions are implemented for direct benefits on child survival, and this is sufficient rationale to provide them. However, there is insufficient information on whether a reduction in mortality in a population with a given health and nutrition intervention also reduces the incidence of severe morbidities, subsequent developmental deficits, or the converse. Even in those reviews that do have meta-analyses of effects on cognitive or motor development, relatively few studies are included, hence our effort at collating the evidence from individual studies that were reported outside meta-analyses.
Research Gaps
There is currently no global set of standard indicators for the measurement of child development, 110 and few direct measures of child development have actually been validated in the LMIC with the highest burdens of undernutrition and developmental delay. 111 Longitudinal data collection in a broader set of countries is needed to quantify the social and economic benefits of MNCH&N interventions, including those deriving from averted developmental delays. 112 Mainstreaming the collection and reporting of child development outcomes for interventions that have a plausible link to developmental processes is needed. Some interventions may confer additional developmental benefits alongside those that are mediated through improved nutrition and reduced infectious disease burden, and they cannot be captured solely through typical anthropometric or clinical measures. A key example is KMC for preterm infants, which can reduce mortality, infection, and hypothermia in addition to improving breastfeeding practices 31 (and so addressing multiple risk factors simultaneously). The recently updated Cochrane review on KMC 113 shows a 50% reduced risk of severe infection or sepsis (risk ratio 0.50, 95% confidence interval 0.36 to 0.69; N = 1463 in 8 studies). Whereas KMC could affect development through mitigating infection and improving nutrition, improved mother-infant attachment 68 suggests additional 
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Implications for Policy and Research
The benefits of maternal health and nutrition interventions in pregnancy for both mother and infant are well established. The consequences of IUGR for child growth and development are myriad and include neurodevelopmental deficits, poorer school performance, and behavioral issues in childhood. 114 At least onefifth of all stunting at 6 months is determined by fetal malnutrition and SGA. 37 Prevention and early detection of IUGR to institute interventions may mitigate detrimental effects on the developing fetus. 21 Limited available evidence suggests that interventions addressing maternal undernutrition and micronutrient deficiencies should start early and preferably before conception. 55 Whereas supporting maternal mental health is essential, antidepressant use during pregnancy may increase the risk of poorer birth outcomes. 115, 116 Perinatal psychosocial support and counseling provided to mothers can be successfully delivered in low-resource settings. 117 Additional research is also needed to understand the effects of violence and stress on maternal mental health and subsequent effects on child development (particularly in conflict zones) so that targeted interventions can be developed.
The findings of this overview further strengthen recommendations for the scale-up of both nutrition and infection prevention and treatment interventions delivered during the prenatal and immediate neonatal period to support both child survival and optimal development. 36 Childbirth and the immediate neonatal period present a variety of risks to both mother and child, particularly for infants who are born preterm or SGA and those without access to skilled birth attendance. Recent evidence from rural Nepal (a setting with extremely low coverage of skilled birth attendance) demonstrated a significant association between SGA and low birth weight and poorer neurocognitive outcomes. 118 In a high-income setting, moderate preterm birth combined with SGA has been associated with general cognitive deficits in adolescents 18 years later, although the study subgroup size was small. 119, 120 Links between preventable intrauterine and neonatal disease and neurodevelopmental outcomes have also been demonstrated, with preterm birth and neonatal sepsis being associated with substantially increased risk of ≥1 neurocognitive or motor deficit. 23 There exists ample evidence supporting the benefits of breastfeeding, yet global coverage of this intervention remains low with little change over time. Implementing breastfeeding promotion and support strategies also necessitates investments in strategies to secure appropriate maternity leave, supportive work environments, and protection of this precious public health intervention from inappropriate marketing of breast milk substitutes. Further highlighting the critical role of nutrition in early developmental processes are recent findings from the Pelotas birth cohort in Brazil, where 30 years later, breastfeeding was found to be associated with intelligence and educational attainment. 120 A large-cluster randomized trial of breastfeeding promotion using the Baby-Friendly Hospital Initiative model in Belarus found that this intervention significantly increased verbal IQ at 6.5 years. 82 Recent metaanalyses of the effect of a variety of macronutrient and micronutrient supplementation programs in children showed small but significant effects on mental development whereas stimulation interventions have shown greater effect sizes, 121 which suggests that delivering nutrition interventions alone may be insufficient. These data collectively reinforce the potential integration of early child health and nutrition interventions with strategies such as stimulation and responsive feeding to optimize development outcomes. 122 Such strategies for integrating early child health, nutrition, and stimulation interventions through community health workers have been successful in rural Pakistan. 123, 124 Overall, the evidence supports existing recommendations for a scale-up of interventions across the continuum of care to reduce mortality and morbidity and for potential benefits to children's cognitive, motor, and socioemotional development. Maintaining an equity focus and targeting specific at-risk populations with both prevention and treatment (eg, undernourished mothers, preterm infants, anemic infants, and rural and underserved populations) is necessary to have maximum impact. Additional research attempting to quantify developmental impacts would strengthen current recommendations and provide governments with additional economic incentives to invest in MNCH&N.
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